Product Details

Nizoral

Ketoconazole
200 mg
Tablet


DIN/PIN/NPN

00633836

Manufacturer

Janssen Inc.

Formulary Listing Date

1996-10-01  

Unit Price

NA

Amount MOH Pays

NA

Coverage Status

Not a Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Nizoral: A low pH is necessary for absorption. Antacids, anticholinergics/antispasmodics, H2-blockers, and omeprazole may decrease absorption. Ketoconazole is a potent inhibitor of hepatic oxidation of drugs and may cause significant elevation of blood levels of astemizole, cisapride, cyclosporine, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of ketoconazole and astemizole, cisapride or terfenadine. Insulin requirements may be reduced. Hepatotoxicity occurs in approximately 1 in 1500 patients treated with ketoconazole for onychomycosis; female gender, pre-existing disease, alcoholism and greater than 2 weeks of therapy are pre-disposing factors.

ATC Code

J02AB02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02231061 Teva-Ketoconazole 0.9393 0.9393
00633836 Nizoral NA NA
02237235 Apo-Ketoconazole 0.9393 0.9393
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph